Precision BioSciences, Inc.
NASDAQ:DTIL
10.3 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 48.727 | 25.098 | 115.529 | 24.285 | 22.238 | 10.883 | 6.484 | 7.015 |
| Kosten van de omzet
| 8.255 | 9.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 40.472 | 16.094 | 115.529 | 24.285 | 22.238 | 10.883 | 6.484 | 7.015 |
| Brutowinstmarge
| 0.831 | 0.641 | 1 | 1 | 1 | 1 | 1 | 1 |
| Onderzoek- en ontwikkelingskosten
| 49.353 | 83.939 | 115.238 | 98.061 | 82.416 | 45.122 | 20.324 | 9.102 |
| Algemene en administratieve kosten
| 39.088 | 41.525 | 39.693 | 36.052 | 27.026 | 13.673 | 8.016 | 0 |
| Verkoop- en marketingkosten
| -4.233 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 34.855 | 41.525 | 39.693 | 36.052 | 27.026 | 13.673 | 8.016 | 6.101 |
| Overige kosten
| 0 | 0 | 0 | 0 | -9.758 | 0 | 0 | 0 |
| Bedrijfskosten
| 84.208 | 125.464 | 154.931 | 134.113 | 109.442 | 58.795 | 28.34 | 15.203 |
| Bedrijfsresultaat
| -43.736 | -100.366 | -39.402 | -109.828 | -87.204 | -47.912 | -21.974 | -8.828 |
| Bedrijfsresultaat ratio
| -0.898 | -3.999 | -0.341 | -4.522 | -3.921 | -4.402 | -3.389 | -1.258 |
| Totaal overige inkomsten en kosten netto
| 1.209 | -11.271 | 8.8 | 0.822 | -5.673 | 1.875 | -0.118 | 0.572 |
| Inkomen voor belasting
| -42.527 | -111.637 | -30.602 | -109.006 | -92.877 | -46.037 | -21.102 | -8.256 |
| Inkomen voor belasting ratio
| -0.873 | -4.448 | -0.265 | -4.489 | -4.176 | -4.23 | -3.254 | -1.177 |
| Belastingkosten
| 27.238 | 11.271 | 0.316 | 10.429 | -9.576 | 1.875 | -0.754 | -0.005 |
| Nettowinst
| -69.765 | -122.908 | -30.918 | -109.006 | -83.301 | -46.037 | -21.102 | -8.251 |
| Nettowinstmarge
| -1.432 | -4.897 | -0.268 | -4.489 | -3.746 | -4.23 | -3.254 | -1.176 |
| WPA (Winst Per Aandeel)
| -18.16 | -41.95 | -15.8 | -62.85 | -59.5 | -28.17 | -18.81 | -4.93 |
| Verwaterde WPA
| -18.16 | -41.95 | -15.8 | -62.85 | -59.5 | -28.17 | -18.81 | -4.93 |
| EBITDA
| -35.481 | -98.472 | -28.813 | -99.193 | -87.378 | -45.558 | -20.303 | -8.188 |
| EBITDA ratio
| -0.728 | -3.923 | -0.249 | -4.085 | -3.929 | -4.186 | -3.131 | -1.167 |